top of page

Semaglutide Dosage Chart: Complete Weekly Dosing Guide

Semaglutide Dosage Chart (2026): Complete Dosing Guide for Safe and Effective Weight Loss

Semaglutide Dosage Chart: Complete Weekly Dosing Guide


Starting semaglutide is not about taking the highest dose as quickly as possible. The medication is intentionally increased over several months to allow your body to adapt, minimize gastrointestinal side effects, and maximize long-term success.


Whether you're prescribed semaglutide for obesity or chronic weight management, understanding the dosing schedule can improve your experience and reduce the likelihood of nausea, vomiting, constipation, and treatment discontinuation.


This guide explains exactly how semaglutide dosing works, why doses increase gradually, what to do if you miss an injection, and when higher doses may—or may not—be necessary.


Semaglutide Dosage Chart


Weeks

Weekly Dose

Goal

1–4

0.25 mg

Allow the body to adjust

5–8

0.5 mg

Begin therapeutic dosing

9–12

1.0 mg

Increase appetite control

13–16

1.7 mg

Continue weight loss

Week 17+

2.4 mg

Maintenance dose

Important: The 0.25 mg starting dose is not intended for significant weight loss. Its primary purpose is to reduce side effects while your digestive system adapts to the medication.


Why Semaglutide Starts at a Low Dose


Semaglutide mimics the naturally occurring GLP-1 hormone, which slows stomach emptying, reduces hunger signals, and increases feelings of fullness.


If treatment began at the full maintenance dose, many patients would experience severe nausea or vomiting. A gradual dose escalation allows your body to adapt while maintaining treatment.


Benefits of dose titration include:


  • Lower risk of nausea

  • Less vomiting

  • Reduced constipation

  • Better long-term adherence

  • Improved patient comfort

  • Higher treatment success rates


What Happens at Each Dose?


Weeks 1–4: 0.25 mg


During the first month, your body begins adapting to semaglutide.


Many patients notice:


  • Reduced appetite

  • Smaller portion sizes

  • Fewer food cravings

  • Earlier fullness


Weight loss during this phase varies considerably. Some individuals lose several pounds, while others experience little change.



Weeks 5–8: 0.5 mg


This is typically when appetite suppression becomes much more noticeable.


Patients often report:


  • Less snacking

  • Reduced emotional eating

  • Decreased food noise

  • Improved portion control


Many people begin experiencing more consistent weekly weight loss during this stage.


Weeks 9–12: 1.0 mg


For many individuals, 1 mg provides meaningful appetite control.


Common improvements include:


  • Longer-lasting fullness

  • Reduced calorie intake

  • Better blood sugar stability

  • Increased consistency in weight loss


Some patients remain on this dose longer if they are responding well and experiencing side effects with dose increases.


Weeks 13–16: 1.7 mg


The transition to 1.7 mg further enhances satiety while preparing the body for maintenance therapy.


Patients often notice:


  • Less interest in highly processed foods

  • Reduced late-night eating

  • Improved meal satisfaction

  • Continued fat loss


Week 17 and Beyond: 2.4 mg


The recommended maintenance dose for chronic weight management is 2.4 mg weekly.


At this stage, semaglutide provides its strongest clinical effect for:


  • Appetite reduction

  • Long-term weight management

  • Craving control

  • Sustained calorie reduction


Not every patient requires 2.4 mg. Some achieve excellent results on lower maintenance doses depending on tolerability and clinical response.


Can You Stay on a Lower Dose?


Yes.


Many healthcare providers individualize treatment rather than increasing the dose on a rigid schedule.


A patient may remain on:


  • 0.5 mg

  • 1.0 mg

  • 1.7 mg


if they continue losing weight, experience good appetite control, and develop bothersome side effects with higher doses.


Treatment should always balance effectiveness with tolerability.


What If You Miss a Dose?


If your missed injection is within 5 days, administer it as soon as possible and resume your regular schedule.


If more than 5 days have passed, skip the missed dose and take your next scheduled injection.


Do not take two doses close together or inject extra medication to make up for a missed dose.


When Should Your Dose Be Delayed?


Dose escalation may be postponed if you experience:


  • Persistent nausea

  • Frequent vomiting

  • Severe constipation

  • Significant dehydration

  • Difficulty eating enough protein or fluids


Remaining on the current dose for several additional weeks often improves tolerability without reducing long-term success.


Common Side Effects During Dose Increases

Side Effect

Most Common During

Nausea

Every dose increase

Constipation

First 2–3 months

Diarrhea

Early treatment

Heartburn

Dose escalation

Bloating

First several weeks

Fatigue

Temporary adjustment

Most side effects improve as the body adapts over time.


Tips for Easier Dose Escalation


Patients who tolerate semaglutide best often follow these habits:


  • Eat smaller meals.

  • Prioritize lean protein.

  • Stay well hydrated.

  • Avoid greasy or fried foods.

  • Eat slowly.

  • Stop eating when comfortably full.

  • Avoid lying down immediately after meals.

  • Continue light physical activity.


These strategies can significantly reduce gastrointestinal symptoms.


Key Takeaways

  • Semaglutide is increased gradually to improve safety and tolerability.

  • The starting dose (0.25 mg) is designed for adaptation, not maximum weight loss.

  • Most patients reach a maintenance dose of 2.4 mg after approximately 17 weeks.

  • Some individuals achieve excellent results on lower doses and may not require further increases.

  • Never increase your dose without guidance from your prescribing clinician.

  • If side effects become difficult to manage, delaying dose escalation is often appropriate and does not necessarily reduce long-term success.



Medical Disclaimer


Last Updated: July 2026


The information provided in this article is for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. It is not intended to replace the guidance of a qualified healthcare professional.


Semaglutide is a prescription medication and should only be used under the supervision of a licensed healthcare provider. Dosage, treatment plans, and medication adjustments should be individualized based on your medical history, current health conditions, treatment goals, and response to therapy.


Do not start, stop, or change your semaglutide dose without consulting your prescribing provider. Taking more medication than prescribed or increasing your dose too quickly may increase the risk of side effects, including severe nausea, vomiting, dehydration, gallbladder disease, pancreatitis, and other serious complications.


If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, difficulty breathing, severe dehydration, vision changes, or symptoms of low blood sugar, seek immediate medical attention.


Begin Reset makes every effort to ensure the medical information published on this website is accurate and up to date. However, medical recommendations, clinical guidelines, and prescribing information may change over time. We do not guarantee that all information is complete, current, or applicable to your individual situation.


By using this website, you acknowledge that no physician-patient relationship is created through the content provided and that all healthcare decisions should be made in consultation with a qualified medical professional.


If you are interested in medical weight loss treatment, schedule a consultation with a licensed Begin Reset provider to determine whether semaglutide is appropriate for you based on your individual health needs.

Comments


bottom of page